Recombinant Chimeric Antibody Development

About Antibodies Incorporated

Antibodies Incorporated is a mature, revenue-generating life sciences tools and reagents company with a diversified portfolio built through both internal development and strategic acquisitions. Its business model centers on manufacturing and distributing highly validated antibodies and associated research consumables across neuroscience, cell signaling, and general cell biology, supported by a global distribution network. The company differentiates itself through deep technical expertise, a 'satisfied or refunded' guarantee, and value-added services like a custom antibody development grant program. Its recent acquisition of Biosensis expands its product offerings and geographic reach, positioning it for continued growth in the research reagents market.